The analysis and interpretation of temporal trends for skin cancer is hampered by difficulties in data collection and interpretation to a larger extent than for most other cancer sites or types. The first problem stems from the coexistence of at least three main histotypes of skin cancer; basal cell carcinoma (BCC), squamous cell carcinoma (SCC), and cutaneous malignant melanoma (CMM), substantially differing from each other from an epidemiological and clinical viewpoint. At the level of death certificates, however, the distinction between the three types of skin cancer is largely unsatisfactory (Percy et al., 1981) . Population-based sources of incidence also present weaknesses ranging from explicit exclusion of skin cancer from certain cancer registration schemes (Parkin et al., 1992) to various degrees of under-notification (Koh et al., 1993) and multiple registration (Young et al., 1981) . Finally, a large proportion of skin cancers, most notably BCC (Harvey et al., 1989; Burton and Armstrong, 1994) , is almost invariably non-fatal, and often treated with out-patient procedures. Incidence rates are thus likely to be heavily influenced by the extent to which people seek medical advice and the skin lesion undergoes surgical resection and histological examination. All these circumstances tend to exaggerate upward trends and, anyhow, make international comparisons difficult.
These factors notwithstanding, several reports of upward trends in mortality and incidence rates of CMM, BCC, SCC and other skin neoplasms have been published, especially from the Australasian Continent (Giles et al., 1989; Brown and Palmer, 1991; Cooke, 1992; Jones et al., 1992; McCredie et al., 1992; MacLennan et al., 1992; Burton et al., 1993) , the US (Glass and Hoover, 1989; Ries et al., 1991; Dennis et al., 1993) , and Europe (Levi et al., 1988; Osterlind et al., 1988; Magnus, 1991; Mackie et al., 1992; Nelemans et al., 1993) , including southern Europe (Franceschi et al., 1992; Pollan and Lopez Abente, 1993; Franceschi et al., 1994) . Data on time trends in the occurrence of BCC and SCC, especially population-based data, are much scantier (Levi et al., 1988; Gallagher et al., 1990; Coebergh et al., 1991; Magnus, 1991; Kaldor et al., 1993; Marks et al., 1993) .
The present study took advantage of a population-based registration system which includes non-melanocytic skin cancer and has been operating since 1976. It was, therefore, possible to update a published population-based series of skin cancer cases (Levi et al., 1988) up to 1992. A particularly favourable environment for skin cancer registration has long been present in this population, since in this region, traditionally, the large majority of cutaneous lesions surgically resected are examined by a pathologist. Thus, previous reports from this series (Levi-atir Chapallaz, 1981; Levi et al., 1988) have been frequently quoted as standard reference figures (Lee, 1982; Giles et al., 1988) . This allows a detailed analysis of time trends of both incidence and mortality of BCC, SCC and CMM, including separate analyses of sexes, various age groups and anatomical subsites.
Materials and methods
The data were abstracted from the Vaud Cancer Registry file, which includes information concerning incident cases of malignant neoplasms in the Canton (whose population, according to the 1990 Census, was about 580 000 inhabitants; Levi et al., 1992 Trend of skin cancer in Swizerland, 1976-92 1976 -80 1981 -85 1986 -90 1991 -92 Total total 1976 -80 1981 -85 1986 -90 1991 Age-specific (15-44, 45-64, 65 years and over) as well as overall age-standardised incidence and mortality rates (world standard population) were computed. Trends in incidence over time were estimated using linear regression of logarithms of age-standardised rates for each histological subtype.
Results
The distribution of 12095 incident cases of skin cancers registered in the Vaud Cancer Registry over the period 1976-92 according to histological type, calendar period and sex is given in Table I . Overall, there were 7830 (65%) BCC (3942 in males, 3888 in females), 3085 (26%) SCC (1707 in males, 1378 in females) and 1180 (10%) CMM (522 in males, 658 in females).
A total of 353 deaths from skin cancer occurred in the period 1976-92 in the Vaud population, and their distribution by histological type (i.e. melanocytic and nonmelanocytic skin cancer) and sex is also given in Table I from SCC, and 31 (9%, 17 in males and 14 in females) from BCC. Age-standardised incidence and mortality rates in three subsequent quinquennia (1976-80, 1981-85, 1986-90) and for the last 2 years are given in Table II , separately for SCC, BCC and CMM and the two sexes. Incidence rates increased substantially over the examined period for all the histological types, ranging from a 44% increase for BCC in males to a more than 3-fold increase for SCC in females. An elevation of approximately 80% was seen from 1976-80 to 1986-90 for CMM incidence in both sexes. For SCC and CMM, in both sexes there were signs of levelling off in 1991-92 after the peak reached in 1986-90. In 1991-92, age-standardised (world) incidence rates per 100000 were 69.3 for basal cell, 29.1 for squamous cell cancers, and 11.5 for melanomas in males and, 62.2, 18.0 and 12.3, respectively, in females.
Over all the examined period the increases in rates ranged between 2.6% per year for BCC incidence in males to 9.0% per year for SCC incidence in females. Yearly increases of CMM were slightly greater than 5% in both sexes. Mortality rates could be examined for the combination of SCC and BCC, and CMM (Table II) . In males, mortality rates increased from 1976-80 and 1990-92 for both nonmelanocytic cancer (>40%) and CMM (>53%), albeit to a lower extent than incidence rates. Conversely, in females, mortality rates for CMM and SCC and BCC combined were stable over the periods examined. In 1991-92, agestandardised mortality rates per 100000 were 2.6 for melanoma and 0.7 for other skin cancers in males, and, 1.6 and 0.2 in females. Age-standardised and age-specific incidence rates of SCC, BCC and CMM by calendar period of diagnosis were plotted in Figure 1 . The upward trends were relatively homogeneous in the two sexes across the three age groups examined. Age-specific rates, but especially those in subjects below age 65, suggest that the incidence of SCC and CMM levelled off over the last period considered. Only in males below age 45 some decline for BCC and SCC was evident over the most recent calendar period. A notable exception is the steady rise of basal cell cancer above age 65 for both sexes.
Cohort-specific analyses of incidence of BCC, SCC and CMM are plotted in Figure 2 . For basal cell carcinomas, steady upward trends were observed in more recent generations for both sexes, although the rises were greater in females, whose rates were higher than for males over the most recent cohorts. The pattern of increasing incidence across subgequent generations was even more consistent for SCC, since in both sexes rates for the more recent generations were 2-to 4-fold higher than for cohorts born two decades earlier. As for BCC, the rises were greater in females than in males. With reference to CMM, in contrast, the upward trends were larger in males than in females who, already, showed higher rates at the beginning of the observation.
The limited numbers of deaths from non-melanocytic skin cancer prevent a meaningful analysis of trends of mortality rates in specific age groups. Figure 3 is restricted, therefore, to the changes of mortality rates in CMM, by sex, overall and in three separate age groups. It is, thus, clear that upward mortality trends were seen in middle-aged men (>25%). In elderly men, after a rise by over 2-fold between 1976 and 1985, mortality remained relatively stable. Conversely, in females, apart from a 2-fold increase in mortality rates of CMM below age 45 years, some decline was evident in the elderly.
Sex-specific trends in skin cancer incidence for four different anatomical sites are shown in Figure 4 . Upward trends were observed for both sexes and various sites. Substantial increases were found in the head and neck for SCC and BCC, but in the trunk for CMM. The largest relative increase was recorded in the upper limbs (including shoulders) for non-melanocytic cancer and, again, in the trunk for CMM.
Changes in the male-to-female ratios of all age-standardised incidence rates from 1976-80 to 1990-92 are considered *'Ill.
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in Figure 5 . In 1991-92 middle-aged women had almost equalled incidence rates of men with respect to BCC. The male-to-female ratio remained similar and close to unity with respect to CMM, with the possible exception of the elderly, where a female excess of CMM incidence seemed to be disappearing already in the early 1980s.
Discussion
The present 17 year population-based study of skin cancer in the Canton of Vaud allows one of the few long-term evaluations of trends of different types of skin cancer published so Trend of skin cancer in Switzerland, 1976 -92 F Levi et al 1051 far. An increase in overall skin cancer incidence, already reported for the period 1976-85 (Levi et al., 1988) , persisted up to 1990 for all skin cancer types, with some hints of a plateau of incidence rates only after 1990, especially in males and with respect to SCC.
The upward trends for non-melanocytic skin cancer are consistent with those reported between 1970 and 1985 in eight out of 13 populations for which incidence data over this period were available (Parkin et al., 1992) . Incidence increases were also documented, separately for BCC and SCC, in a few other populations, based on either cancer registration schemes (Giles et al., 1989; Coebergh et al., 1991; Magnus, 1991; Kaldor et al., 1993) , household national surveys (Fears and Scotto, 1982; Marks et al., 1993) (Glass and Hoover, 1989; Ries et al., 1991 each other (since the ratio declined from 2.4 in 1976-80 to Calendar period 1.6 in 1991-2) and are comparable in middle-aged men and women in the last examined period. Thus, the male-to-female increases of 3-7% recorded in most white popula- (Armstrong, 1988; Kricker et al., 1994) . the last two or three decades (Armstrong, 1988) .
In conclusion, the present study documents in this Swiss so support a few reports of increases in the mid-to population an approximately 2-fold increase of CMM, and )s, which seemed unexpectedly large against the substantial increases also in non-melanocytic cancers over the und of previous long-term trends (Burton and Armlast two decades. The contribution of some increased surveil-1994). 
